Does NIRAPARIB Cause Myelodysplastic syndrome? 127 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 127 reports of Myelodysplastic syndrome have been filed in association with NIRAPARIB (ZEJULA). This represents 0.6% of all adverse event reports for NIRAPARIB.
127
Reports of Myelodysplastic syndrome with NIRAPARIB
0.6%
of all NIRAPARIB reports
32
Deaths
43
Hospitalizations
How Dangerous Is Myelodysplastic syndrome From NIRAPARIB?
Of the 127 reports, 32 (25.2%) resulted in death, 43 (33.9%) required hospitalization, and 50 (39.4%) were considered life-threatening.
Is Myelodysplastic syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIRAPARIB. However, 127 reports have been filed with the FAERS database.
What Other Side Effects Does NIRAPARIB Cause?
Nausea (5,794)
Fatigue (5,240)
Constipation (4,128)
Platelet count decreased (4,102)
Insomnia (2,861)
Blood pressure increased (2,464)
Headache (2,383)
Off label use (2,213)
Vomiting (2,029)
Carbohydrate antigen 125 increased (1,868)
What Other Drugs Cause Myelodysplastic syndrome?
CYCLOPHOSPHAMIDE (1,545)
LENALIDOMIDE (1,285)
DOXORUBICIN (1,236)
RITUXIMAB (1,054)
VINCRISTINE (966)
ETOPOSIDE (936)
DEXAMETHASONE (759)
METHOTREXATE (728)
CYTARABINE (715)
CARBOPLATIN (698)
Which NIRAPARIB Alternatives Have Lower Myelodysplastic syndrome Risk?
NIRAPARIB vs NIRMATRELVIR\RITONAVIR
NIRAPARIB vs NIROGACESTAT
NIRAPARIB vs NIROGACESTAT HYDROBROMIDE
NIRAPARIB vs NIRSEVIMAB
NIRAPARIB vs NIRSEVIMAB-ALIP